Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1536895 | 1.00 | TSHR (0.40) | TSHRALDH1A1LMNAUSP2CYP3A4 | |
| SCHEMBL533948 | 1.00 | TSHR (0.40) | TSHRALDH1A1LMNAUSP2CYP3A4 | |
| SCHEMBL14436734 | 0.85 | — | — | |
| SCHEMBL10634984 | 0.82 | LMNA (0.49) | TSHRALDH1A1LMNAUSP2CYP3A4 | |
| SCHEMBL2286811 | 0.80 | TSHR (0.38) | TSHRALDH1A1LMNAUSP2CYP3A4 | |
| SCHEMBL534005 | 0.80 | TSHR (0.38) | TSHRALDH1A1LMNAUSP2CYP3A4 | |
| SCHEMBL6731503 | 0.79 | ALDH1A1 (0.50) | TSHRALDH1A1LMNAUSP2CYP3A4 | |
| SCHEMBL6720512 | 0.79 | ALDH1A1 (0.50) | TSHRALDH1A1LMNAUSP2CYP3A4 | |
| SCHEMBL6731505 | 0.79 | ALDH1A1 (0.50) | TSHRALDH1A1LMNAUSP2CYP3A4 | |
| SCHEMBL6720513 | 0.79 | ALDH1A1 (0.50) | TSHRALDH1A1LMNAUSP2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713286-B2 | Butadiene telomerization catalyst preparation and use thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-08-01 | — | — | US | claimed |
| EP-3741769-B1 | BUTADIENE TELOMERIZATION CATALYST PRECURSOR PREPARATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-28 | — | — | EP | claimed |
| US-20220213006-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-07-07 | — | — | US | claimed |
| US-11312670-B2 | Butadiene telomerization catalyst and preparation thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-26 | — | — | US | claimed |
| EP-3741769-A1 | BUTADIENE TELOMERIZATION CATALYST PRECURSOR PREPARATION | Dow Global Technologies Llc (US) | 2020-11-25 | — | — | EP | claimed |
| EP-3080136-B1 | BUTADIENE TELOMERIZATION CATALYST PRECURSOR PREPARATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-10-28 | — | — | EP | claimed |
| CN-107438630-B | Butadiene short-chain polymerization catalyst and preparation thereof | 陶氏环球技术有限责任公司 | 2020-09-15 | — | — | CN | claimed |
| US-10751706-B2 | Butadiene telomerization catalyst precursor preparation | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-08-25 | — | — | US | claimed |
| US-20200147596-A1 | BUTADIENE TELOMERIZATION CATALYST PRECURSOR PREPARATION | DOW GLOBAL TECHNOLOGIES LLC | 2020-05-14 | — | — | US | claimed |
| US-10569262-B2 | Butadiene telomerization catalyst precursor preparation | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-02-25 | — | — | US | claimed |
| US-5254782-A | Reacting conjugated diene with compound containing active hydrogen in liquid phase in presence of group 8 compound catalst and promoter | THE DOW CHEMICAL COMPANY (US) | 1993-10-19 | — | — | US | claimed |
| EP-0461222-A1 | CONTINUOUS PROCESS FOR THE TELOMERIZATION OF CONJUGATED DIENES. | DOW CHEMICAL CO (US) | 1991-12-18 | — | — | EP | claimed |
| WO-1991009822-A1 | CONTINUOUS PROCESS FOR THE TELOMERIZATION OF CONJUGATED DIENES | DOW BENELUX N.V. (NL) | 1991-07-11 | — | — | WO | claimed |
| US-5004568-A | Reacting With Carbon Monoxide Using A Group 8 Noble Metal Halide Catalyst And A Group 1B Metal Halide | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1991-04-02 | — | — | US | claimed |
| EP-0217407-B1 | CARBONYLATION OF ALLYLIC ETHERS TO ESTERS | QUANTUM CHEMICAL CORPORATION (a Virginia corp.) (US) | 1991-03-06 | — | — | EP | claimed |
| US-4767574-A | CATALYTIC WITH GROUP 8 NOBLE METAL HALIDE AND HALIDE COMPOUND | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1988-08-30 | — | — | US | claimed |
| US-4721820-A | CUPRIC CHLORIDE OR BROMIDE OR PALLADIUM HALIDE CATALYST | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1988-01-26 | — | — | US | claimed |
| EP-0217407-A2 | Carbonylation of allylic ethers to esters | QUANTUM CHEMICAL CORPORATION (a Virginia corp.) (US) | 1987-04-08 | — | — | EP | claimed |
| US-4633021-A | AUTHENIUM CHRBONYL COMPLEXES AS CATALYST; SOLVENT EXTRACTION OF ALDEHYDE AND RECYCLING CATALYST | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1986-12-30 | — | — | US | claimed |
| US-4622416-A | GROUP 8 HALIDE CATALYSTS | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1986-11-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11312670-B2 | Butadiene telomerization catalyst and preparation thereof | TELO2, TERT, POT1 | TSHR 1679/4885ALDH1A1 824/4885LMNA 1090/4885 |
| US-11713286-B2 | Butadiene telomerization catalyst preparation and use thereof | TELO2, TERT, TPR | TSHR 1701/4885ALDH1A1 954/4885LMNA 886/4885 |
| US-10569262-B2 | Butadiene telomerization catalyst precursor preparation | TELO2, TERT, MCM7 | TSHR 4557/4885ALDH1A1 1545/4885LMNA 356/4885 |
| US-20220213006-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | TELO2, TERT, TPR | TSHR 1701/4885ALDH1A1 954/4885LMNA 886/4885 |
| US-10751706-B2 | Butadiene telomerization catalyst precursor preparation | TELO2, TERT, MCM7 | TSHR 4557/4885ALDH1A1 1545/4885LMNA 356/4885 |
| US-20200147596-A1 | BUTADIENE TELOMERIZATION CATALYST PRECURSOR PREPARATION | TELO2, TERT, TERB1 | TSHR 4496/4885ALDH1A1 1444/4885LMNA 370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.